A&M STABTEST

A&M STABTEST is one of Europe’s leading providers of pharmaceutical analysis services. The company specializes in stability and release testing for both small molecules and biologics—including biosimilars—and has developed robust QC methods to support innovative formulations such as orally inhaled and nasal products. They operate two main sites in Germany with over 350 staff members. Their Biopharma Competence Centre focuses on biologics QC-testing including stability storage, instrumental/functional biological testing, and packaging material analysis under GMP standards. The Mainz site specializes in small molecule drug testing. They have supported major industry milestones such as registration studies for some of the world’s first biosimilars.